-
RENAL RISK STRATIFICATION IN ON-PUMP AND OFF-PUMP CORONARY ARTERY BYPASS SURGERY
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL OUTCOMES IN KRAS(G12C) METASTATIC COLORECTAL CANCER IN THE UNITED STATES AND CANADA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
NOVEL THERAPIES FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA POST BRUTON’S TYROSINE KINASE INHIBITOR: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
THE ADHERENCE ILLUSION: WHY ADHERENT-ONLY RESULTS CANNOT GENERALLY INFORM REAL WORLD DECISIONS
Mar 18, 2026, 21:38 PM -
HEALTH CARE RESOURCE USE IN RARE DISEASE CLINICAL TRIALS: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
BEYOND “CURED”: PREFERRED TERMINOLOGY, MILESTONES, AND EVIDENCE FOR PAYER DECISION-MAKING IN EARLY-STAGE MELANOMA
Mar 18, 2026, 21:38 PM -
COMPARING 1.5% RUXOLITINIB CREAM AND OTHER THERAPIES FOR PEDIATRIC PATIENTS WITH ATOPIC DERMATITIS: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE PHENYLKETONURIA-SYMPTOM SEVERITY AND IMPACTS SCALE (PKU-SSIS) IN ADULTS WITH PKU
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF CRS AND ICANS SEVERITY ACROSS SIX COMMERCIAL CAR-T THERAPIES
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ONCOLOGY MEDICINES IN LATIN AMERICA: AVAILABILITY AND TIME-TO-ACCESS ACROSS HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
INCORPORATING REAL-WORLD EVIDENCE INTO TIME-TO-EVENT EXTRAPOLATIONS FROM CLINICAL TRIAL DATA
Mar 18, 2026, 21:38 PM -
EVALUATING THE ECONOMIC VALUE OF MONOCLONAL ANTIBODIES FOR AQP4+ NMOSD IN THE US USING ATTACK-FREE SURVIVAL OVER A 5-YEAR HORIZON
Mar 18, 2026, 21:38 PM -
LEVERAGING INVERSE PROBABILITY WEIGHTING TO ADDRESS TIME-DEPENDENT BIAS INTRODUCED BY NONRESPONSE IN REAL-WORLD LONGITUDINAL RESEARCH INVOLVING PATIENT-REPORTED OUTCOME MEASURES
Mar 18, 2026, 21:38 PM -
EXPLORING THE OPTIMAL SHARE OF PHARMACEUTICAL VALUE FOR INDUSTRY AND SOCIETY: AN APPLICATION TO THE US CONTEXT
Mar 18, 2026, 21:38 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
FROM TEXT TO SIGNAL: EVALUATING LLMS FOR VALID CASE IDENTIFICATION IN PHARMACOVIGILANCE
Mar 18, 2026, 21:38 PM -
BURDEN OF DISEASE IN ADOLESCENT HIDRADENITIS SUPPURATIVA: AN OBSERVATIONAL COHORT STUDY
Mar 18, 2026, 21:38 PM -
THE ROLE OF SYSTEMIC INFLAMMATION IN THE ASSOCIATION OF OBESITY WITH MORTALITY AND HEALTH OUTCOMES AMONG COPD PATIENTS: A MEDIATION ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD PATTERNS OF CTDNA TESTING, MOLECULAR RESIDUAL DISEASE, AND TREATMENT AFTER RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
Mar 18, 2026, 21:38 PM -
COST-UTILITY ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE VERSUS FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL FOR MODERATE-TO-VERY SEVERE COPD IN CHINA
Mar 18, 2026, 21:38 PM
